Carat Pharmaceuticals Private Limited
About Carat Pharmaceuticals Private Limited
Data last updated:
Carat Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 September 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2016PTC286012. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Lokesh Kishanlal Jaiswal and Rohit Kishanlal Jaiswal.
The registered office is at Mumbai, Maharashtra.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressShop No.8 – 9 Gr Floor Mahindra Tower(Munpl Chawl) Pandurang Budhkar Marg Nr. Doordarshan, Kendra, Mumbai, Maharashtra, India – 400013
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Carat Pharmaceuticals Private Limited
Financial Statement Summary of Carat Pharmaceuticals Private Limited
| Metrics | FY 2016-17 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | •••• |
| Other Income | •••• |
| Total Revenue | •••• |
| Cost of Materials Consumed | •••• |
| Employee Benefit Expense | •••• |
| Finance Costs | •••• |
| Depreciation and Amortisation | •••• |
| Other Expenses | •••• |
| Total Expenses | •••• |
| EBITDA | •••• |
| Profit Before Tax | •••• |
| Tax Expense | •••• |
| Net Profit (PAT) | •••• |
| Balance Sheet | |
| Share Capital | •••• |
| Reserves and Surplus | •••• |
| Net Worth (Total Equity) | •••• |
| Long-term Borrowings | •••• |
| Short-term Borrowings | •••• |
| Trade Payables | •••• |
| Total Liabilities | •••• |
| Fixed Assets | •••• |
| Investments | •••• |
| Inventories | •••• |
| Trade Receivables | •••• |
| Cash and Bank Balance | •••• |
| Total Assets | •••• |
Financial Ratios of Carat Pharmaceuticals Private Limited
| Metrics | FY 2016-17 |
|---|---|
| Profitability | |
| EBITDA Margin | •••• |
| Net Profit Margin | •••• |
| Return on Equity (ROE) | •••• |
| Return on Capital Employed (ROCE) | •••• |
| Return on Assets (ROA) | •••• |
| Liquidity and Debt | |
| Current Ratio | •••• |
| Quick Ratio | •••• |
| Debt-to-Equity Ratio | •••• |
| Interest Coverage Ratio | •••• |
| Efficiency and Growth | |
| Asset Turnover | •••• |
| Receivable Days | •••• |
| Payable Days | •••• |
| Inventory Days | •••• |
| Revenue Growth | •••• |
| Net Profit Growth | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Carat Pharmaceuticals are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Auditor Details of Carat Pharmaceuticals Private Limited
Carat Pharmaceuticals Private Limited is audited by Agarwal Ritu & Associates for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Agarwal Ritu & Associates | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Carat Pharmaceuticals Private Limited
Carat Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Lokesh Kishanlal Jaiswal Also directs: High-Performance Diagnostic Center (OPC) Private Limited | Director | 19 Sep 2016 | 10 Years 0 Months | Current |
| Rohit Kishanlal Jaiswal | Director | 19 Sep 2016 | 10 Years 0 Months | Current |
Ownership and Shareholding of Carat Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Carat Pharmaceuticals Private Limited
Carat Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Carat Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Carat Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Carat Pharmaceuticals Private Limited
Carat Pharmaceuticals Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Lokesh Kishanlal Jaiswal was appointed as Director on 19 Sep 2016.
Credit Ratings, Litigation & Regulatory Alerts for Carat Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Carat Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Carat Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Carat Pharmaceuticals Private Limited
Carat Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Carat Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Carat Pharmaceuticals Private Limited
Carat Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 September 2016 (10+ years old) and is registered under CIN U51909MH2016PTC286012.
Carat Pharmaceuticals has 2 current directors:
- Lokesh Kishanlal Jaiswal - Director
- Rohit Kishanlal Jaiswal - Director
No. Carat Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Carat Pharmaceuticals is U51909MH2016PTC286012. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Carat Pharmaceuticals was incorporated on 19 September 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.
Lokesh Kishanlal Jaiswal was appointed as Director on 19 Sep 2016. Rohit Kishanlal Jaiswal was appointed as Director on 19 Sep 2016.
The registered office of Carat Pharmaceuticals is at Shop No.8 – 9 Gr Floor Mahindra TowerMunpl Chawl Pandurang Budhkar Marg Nr. Doordarshan, Kendra, Mumbai, Maharashtra, India – 400013.
Carat Pharmaceuticals has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.
Carat Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
No. Carat Pharmaceuticals is not listed on any stock exchange. It is an unlisted company.